Table 1 Percentage of total TetE7+CD8+ and CD8+ cells in the spleen and GLN of E7-vaccinated mice IVAG challenged with different immunostimulants

From: Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice

 

Spleen

GLN

IVAG immunostimulant

Tet E7 + CD8 + (mean percentage±s.e.m.)

CD8 + (mean percentage±s.e.m.)

Tet E7 + CD8 + (mean percentage±s.e.m.)

CD8 + (mean percentage±s.e.m.)

PBS

0.65±0.09 (10)a

12.26±0.96 (10)

0.18±0.05 (10)

18.33±0.65 (10)

CpG

0.74±0.17 (7)

10.18±0.79 (7)

0.21±0.07 (7)

18.04±0.98 (7)

PIC

0.49±0.06 (4)

10.05±1.22 (4)

0.15±0.02 (4)

18.79±0.44 (4)

  1. Abbreviations: IVAG, intravaginal; GLN, genital lymph node; PBS, phosphate-buffered saline.
  2. aThe number of mice in each group is indicated in parenthesis.
PowerPoint slide
Back to article page